Literature DB >> 24382453

The PSD protein ProSAP2/Shank3 displays synapto-nuclear shuttling which is deregulated in a schizophrenia-associated mutation.

Stefanie Grabrucker1, Christian Proepper2, Katharina Mangus3, Matti Eckert3, Resham Chhabra3, Michael J Schmeisser2, Tobias M Boeckers2, Andreas M Grabrucker4.   

Abstract

Recently, mutations in ProSAP2/Shank3 have been discovered as one of the genetic factors for schizophrenia (SCZ). Here, we show that the postsynaptic density protein ProSAP2/Shank3 undergoes activity dependent synapse-to-nucleus shuttling in hippocampal neurons. Our study shows that the de novo mutation (R1117X) in ProSAP2/Shank3 that was identified in a patient with SCZ leads to an accumulation of mutated ProSAP2/Shank3 within the nucleus independent of synaptic activity. Furthermore, we identified novel nuclear ProSAP2/Shank3 interaction partners. Nuclear localization of mutated ProSAP2/Shank3 alters transcription of several genes, among them already identified genetic risk factors for SCZ such as Synaptotagmin 1 and LRRTM1. Comparing the SCZ mutation of ProSAP2/Shank3 to the knockdown of ProSAP2/Shank3 we found some shared features such as reduced synaptic density in neuronal cultures. However, hippocampal neurons expressing the ProSAP2/Shank3 SCZ mutation furthermore show altered E/I ratio and reduced dendritic branching. Thus, we conclude that the uncoupling of ProSAP2/Shank3 nuclear shuttling from synaptic activity may represent a molecular mechanism that contributes to the pathology of SCZ in patients with mutations in ProSAP2/Shank3.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autism; LRRTM1; Nuclear shuttling; PSD; SCZ; Shank3; Synapse; Synaptotagmin 1; hnRNP

Mesh:

Substances:

Year:  2013        PMID: 24382453     DOI: 10.1016/j.expneurol.2013.12.015

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  24 in total

1.  A recurrent deletion syndrome at chromosome bands 2p11.2-2p12 flanked by segmental duplications at the breakpoints and including REEP1.

Authors:  Servi J C Stevens; Eveline W Blom; Ingrid T J Siegelaer; Eric E J G L Smeets
Journal:  Eur J Hum Genet       Date:  2014-07-02       Impact factor: 4.246

2.  Sensitivity to isoflurane anesthesia increases in autism spectrum disorder Shank3+/∆c mutant mouse model.

Authors:  Changsheng Li; Michele Schaefer; Christy Gray; Ya Yang; Orion Furmanski; Sufang Liu; Paul Worley; C David Mintz; Feng Tao; Roger A Johns
Journal:  Neurotoxicol Teratol       Date:  2016-11-14       Impact factor: 3.763

Review 3.  Comparison of SHANK3 deficiency in animal models: phenotypes, treatment strategies, and translational implications.

Authors:  Jan Philipp Delling; Tobias M Boeckers
Journal:  J Neurodev Disord       Date:  2021-11-16       Impact factor: 4.025

4.  SHANK3 deficiency leads to myelin defects in the central and peripheral nervous system.

Authors:  Mariagiovanna Malara; Anne-Kathrin Lutz; Berra Incearap; Helen Friedericke Bauer; Silvia Cursano; Katrin Volbracht; Joanna Janina Lerner; Rakshita Pandey; Jan Philipp Delling; Valentin Ioannidis; Andrea Pérez Arévalo; Jaime Eugenin von Bernhardi; Michael Schön; Jürgen Bockmann; Leda Dimou; Tobias M Boeckers
Journal:  Cell Mol Life Sci       Date:  2022-06-20       Impact factor: 9.207

5.  SHANK3 Antibody Validation: Differential Performance in Western Blotting, Immunocyto- and Immunohistochemistry.

Authors:  Anne-Kathrin Lutz; Helen Friedericke Bauer; Valentin Ioannidis; Michael Schön; Tobias M Boeckers
Journal:  Front Synaptic Neurosci       Date:  2022-06-06

6.  A bidirectional switch in the Shank3 phosphorylation state biases synapses toward up- or downscaling.

Authors:  Chi-Hong Wu; Vedakumar Tatavarty; Pierre M Jean Beltran; Andrea A Guerrero; Hasmik Keshishian; Karsten Krug; Melanie A MacMullan; Li Li; Steven A Carr; Jeffrey R Cottrell; Gina G Turrigiano
Journal:  Elife       Date:  2022-04-26       Impact factor: 8.713

7.  Novel Shank3 mutant exhibits behaviors with face validity for autism and altered striatal and hippocampal function.

Authors:  Thomas C Jaramillo; Haley E Speed; Zhong Xuan; Jeremy M Reimers; Christine Ochoa Escamilla; Travis P Weaver; Shunan Liu; Irina Filonova; Craig M Powell
Journal:  Autism Res       Date:  2016-08-05       Impact factor: 5.216

8.  Shank3-mutant mice lacking exon 9 show altered excitation/inhibition balance, enhanced rearing, and spatial memory deficit.

Authors:  Jiseok Lee; Changuk Chung; Seungmin Ha; Dongmin Lee; Do-Young Kim; Hyun Kim; Eunjoon Kim
Journal:  Front Cell Neurosci       Date:  2015-03-19       Impact factor: 5.505

9.  Phenotypic and functional analysis of SHANK3 stop mutations identified in individuals with ASD and/or ID.

Authors:  Daniela M Cochoy; Alexander Kolevzon; Yuji Kajiwara; Michael Schoen; Maria Pascual-Lucas; Stacey Lurie; Joseph D Buxbaum; Tobias M Boeckers; Michael J Schmeisser
Journal:  Mol Autism       Date:  2015-04-29       Impact factor: 7.509

10.  Cellular Zinc Homeostasis Contributes to Neuronal Differentiation in Human Induced Pluripotent Stem Cells.

Authors:  Stefanie Pfaender; Karl Föhr; Anne-Kathrin Lutz; Stefan Putz; Kevin Achberger; Leonhard Linta; Stefan Liebau; Tobias M Boeckers; Andreas M Grabrucker
Journal:  Neural Plast       Date:  2016-05-09       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.